Metraipolis › archive › dc_9161cc3cb4eb

Health-Related Quality of Life and Symptom Burden in Patients with Diffuse Large B-Cell Lymphoma Before Treatment with Tafasitamab and Lenalidomide: An Ad Hoc… — Europe PMC PMID:41439940

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41439940
DOI
10.3390/diseases13120399
License (as archived)
solo-consultazione
Archived
2026-11-07T15:48:40.161Z
SHA-256 of the archived text
e9874ac1200949ab2e8498bc8071a39ddbf46a11dc0bc89077291b7ece335621
Stable URL of this page
https://metraipolis.com/documento/dc_9161cc3cb4eb

How to cite

Health-Related Quality of Life and Symptom Burden in Patients with Diffuse Large B-Cell Lymphoma Before Treatment with Tafasitamab and Lenalidomide: An Ad Hoc… — Europe PMC PMID:41439940 — Europe PMC (en), https://europepmc.org/article/MED/41439940 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9161cc3cb4eb (Metraipolis archive dc_9161cc3cb4eb, sha256 e9874ac1200949ab2e8498bc8071a39ddbf46a11dc0bc89077291b7ece335621)
BibTeX
@misc{dc9161cc3cb4eb,
  title = {Health-Related Quality of Life and Symptom Burden in Patients with Diffuse Large B-Cell Lymphoma Before Treatment with Tafasitamab and Lenalidomide: An Ad Hoc… — Europe PMC PMID:41439940},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41439940},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9161cc3cb4eb; sha256 e9874ac1200949ab2e8498bc8071a39ddbf46a11dc0bc89077291b7ece335621},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41439940. Agents can read the archived copy with the MCP tool read_document.